Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide vs placebo in type 2 diabetes inadequately controlled on metformin plus pioglitazone
2008-001744-39Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Taspoglutide arm with Placebo arm (2 arms). Primary endpoints: Absolute change from baseline in fasting plasma glucose (FPG) and Absolute change from baseline in HbA1c. Started Aug 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001744-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001744-39.